Intest Res Search

CLOSE


Article category

  • HOME
  • ARTICLE CATEGORY
  • Article category
Urinary chitinase 3-like 1 and intestinal fatty-acid binding proteins are not elevated in children with inflammatory bowel disease
Shaun Siong Chung Ho, Jacqueline Ilene Keenan, Andrew Stewart Day
Intest Res. 2022;20(4):509-513.   Published online July 22, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care
Alex Barnes, David Carter, Patricia Kaazan, Alissa Walsh, Susan Connor, Jane M Andrews
Intest Res. 2022;20(4):506-508.   Published online April 26, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis?
Aikaterini Mantaka, Nikolaos Galanakis, Dimitrios Tsetis, Ioannis E. Koutroubakis
Intest Res. 2022;20(4):495-505.   Published online August 8, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis
Jong Yop Pae, Eun Soo Kim, Sung Kook Kim, Min Kyu Jung, Jun Heo, Jang Hoon Lee, Min Ae Park
Intest Res. 2022;20(4):482-494.   Published online April 15, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study
Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, Katsuhiro Arai
Intest Res. 2022;20(4):475-481.   Published online June 13, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
Haruka Otake, Satohiro Matsumoto, Hirosato Mashima
Intest Res. 2022;20(4):464-474.   Published online March 31, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park
Intest Res. 2022;20(4):452-463.   Published online March 11, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary MaterialGraphic abstract
Close layer
prev next
Efficacy of hepatitis B vaccination in patients with ulcerative colitis: a prospective cohort study
Anurag Mishra, Amarender Singh Puri, Sanjeev Sachdeva, Ashok Dalal
Intest Res. 2022;20(4):445-451.   Published online February 8, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements
Yong Eun Park, Yoo Jin Lee, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seong-Eun Kim, Seung-Jae Myung
Intest Res. 2022;20(4):431-444.   Published online January 5, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Natural history of inflammatory bowel disease: a comparison between the East and the West
Eun Mi Song, Suk-Kyun Yang
Intest Res. 2022;20(4):418-430.   Published online December 2, 2021
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies
Priscila A. Lima, Bárbara B. Berg, Marina Gomes Miranda e Castor
Intest Res. 2022;20(4):392-417.   Published online May 31, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education
Seulji Kim, Seong-Joon Koh
Intest Res. 2022;20(4):389-391.   Published online October 28, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Update on SARS-CoV-2 vaccination of patients with inflammatory bowel disease: what clinicians need to know
Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Seung-Jae Myung, Clinical Practice Guideline Committee of the Korean Association for the Study of Intestinal Diseases
Intest Res. 2022;20(3):386-388.   Published online March 11, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis
Jim O’Connell, Jayne Doherty, Amy Buckley, David Cormican, Cara Dunne, Karen Hartery, John Larkin, Finbar MacCarthy, Paul McCormick, Susan McKiernan, Brian Mehigan, Cian Muldoon, Ciara Ryan, Jacintha O’Sullivan, David Kevans
Intest Res. 2022;20(3):381-385.   Published online March 11, 2022
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn’s disease
Shigeki Bamba, Osamu Inatomi, Atsushi Nishida, Masashi Ohno, Takayuki Imai, Kenichiro Takahashi, Yuji Naito, Junichi Iwamoto, Akira Honda, Naohiro Inohara, Akira Andoh
Intest Res. 2022;20(3):370-380.   Published online May 14, 2021
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary MaterialGraphic abstract
Close layer
prev next
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD

ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2022 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next